Venture Capital

Cenova Ventures

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Private Equity, Venture Capital

Stage Focus
Early Stage, Growth

Geographical Focus
China

Industries Focus

  • Healthcare
  • Healthcare Services
  • Digital Health
  • Pharmaceuticals
  • Medical Devices
  • Diagnostics
  • Biotechnology
  • Medical Technology

Investment Size:
1,000,000 to 50,000,000 USD

Investor Details Founded: 2010

Cenova Ventures is a prominent venture capital firm based in Shanghai, China, focusing on early and growth-stage investments in the healthcare sector. The firm primarily invests in healthcare services, diagnostics, medical devices, and pharmaceuticals, aiming to support the transformation of China's healthcare system into a more efficient, market-oriented model.

Established in 2010, Cenova Ventures has managed multiple funds and invested in over 50 companies across various healthcare sub-sectors. The firm's investors include large domestic and international institutional investors, such as Asian sovereign wealth funds, government institutions, insurance and financial institutions, and multinational companies.

Cenova Ventures has a proven track record with notable exits, including AnHeart Therapeutics, Aohua, and Baikemy.com. The firm's strategic focus and deep industry expertise have positioned it as a leading investor in China's evolving healthcare landscape.

Requirements
  • Innovative healthcare solutions
  • Strong management teams
  • Scalable business models
  • Alignment with market trends
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • AnHeart Therapeutics
  • Aohua
  • Baikemy.com
  • Vivace Therapeutics
  • Weimai
  • Haofeng Medtech
  • Agile Medical
  • Jiangsu Jland Biotech
  • Sieran Medical
  • ASLAN Pharmaceuticals
Claim this Investor

Are you an official representative of Cenova Ventures?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim